Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.
|
|
New York Times (10.27.09) - Friday, October 30, 2009
Susan Okie
The National Institute of Allergy and Infectious Diseases (NIAID) is paying to study the "test and treat" strategy to see whether barriers to diagnosis and medical care can be surmounted. CDC recommends universal, voluntary HIV testing of people ages 13-64 as part of routine medical care in doctors' offices, clinics, and emergency departments.
In both communities, researchers have been meeting with hospital and health officials to discuss the adoption of CDC's recommendation. Testing may also be offered in non-medical settings, said Dr. Anthony S. Fauci, NIAID's director.
In the District, one-third to one-half of those with HIV have not been diagnosed. Further, of people who tested positive in 2006, only 50 percent sought a doctor's care for HIV within six months.
Someone who tests positive in the field "can walk off that day and decide, 'I'm going to pretend that never happened,'" said Angela Fulwood Wood, deputy director of Family and Medical Counseling Service, which does mobile HIV rapid testing in the District. "There are so many people who test 'preliminary reactive' who never return," said Torena White, head of an FMCS outreach team. Training for community workers, therefore, emphasizes getting those infected into treatment.
The Bronx has the highest AIDS mortality rate of any New York City borough, though Manhattan has a higher rate of cases. In the first half of 2008, "more than a quarter of the people who were tested in the Bronx had AIDS by the time they received their [first HIV-related] diagnosis," said Dr. Monica Sweeney, the city's assistant health commissioner for HIV prevention and control.
"Routine testing at either emergency rooms or physicians' offices - I think that's our biggest chance of really catching people earlier," especially those who do not perceive they are at risk of infection, said Wood.
091030
AD091866
Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from the Elton John AIDS Foundation, National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.